Branched‐chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases
Obesity Reviews · 2025-02 · 26 (2)
DOI: 10.1111/obr.13856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, online erschienen am 25.10.2024. Verfasst von Shama Mansoori und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China. Hauptthemen laut MEDLINE: Amino Acids, Branched-Chain. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PolyU- Project of Strategic Importance, National Natural Science Foundation of China, Research Grant Council Collaborative Research Fund.
Abstract (Originalsprache)
Branched‐chain amino acids (BCAAs), including leucine, isoleucine, and valine, are essential for maintaining physiological functions and metabolic homeostasis. However, chronic elevation of BCAAs causes metabolic diseases such as obesity, type 2 diabetes (T2D), and metabolic‐associated fatty liver disease (MAFLD). Adipose tissue, skeletal muscle, and the liver are the three major metabolic tissues not only responsible for controlling glucose, lipid, and energy balance but also for maintaining BCAA homeostasis. Under obese and diabetic conditions, different pathogenic factors like pro‐inflammatory cytokines, lipotoxicity, and reduction of adiponectin and peroxisome proliferator‐activated receptors γ (PPARγ) disrupt BCAA metabolism, leading to excessive accumulation of BCAAs and their downstream metabolites in metabolic tissues and circulation. Mechanistically, BCAAs and/or their downstream metabolites, such as branched‐chain ketoacids (BCKAs) and 3‐hydroxyisobutyrate (3‐HIB), impair insulin signaling, inhibit adipogenesis, induce inflammatory responses, and cause lipotoxicity in the metabolic tissues, resulting in multiple metabolic disorders. In this review, we summarize the latest studies on the metabolic regulation of BCAA homeostasis by the three major metabolic tissues—adipose tissue, skeletal muscle, and liver—and how dysregulated BCAA metabolism affects glucose, lipid, and energy balance in these active metabolic tissues. We also summarize therapeutic approaches to restore normal BCAA metabolism as a treatment for metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
- Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, China.
ORCID-Profile: Kenneth King-Yip Cheng
Förderung
- PolyU- Project of Strategic Importance
- National Natural Science Foundation of China
- Research Grant Council Collaborative Research Fund
- General Research Fund (GRF), Hong Kong Research Grant Council (RGC)
- Shenzhen Municipal Science and Technology Innovation Commission
- PolyU- Project of RCMI
- General Research Fund of Shanghai Normal University
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Mansoori, S., Ho, M. Y., Ng, K. K., & Cheng, K. K. (2025). Branched‐chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases. Obesity Reviews, 26(2). https://doi.org/10.1111/obr.13856
Vancouver
Mansoori S, Ho MY, Ng KK, Cheng KK. Branched‐chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases. Obesity Reviews. 2025;26(2). doi:10.1111/obr.13856
BibTeX
@article{Mansoori2025,
author = {Mansoori, Shama and Ho, Melody Yuen-Man and Ng, Kelvin Kwun-Wang and Cheng, Kenneth King-Yip},
title = {Branched‐chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases},
journal = {Obesity Reviews},
year = {2025},
volume = {26},
number = {2},
doi = {10.1111/obr.13856}
}
EUVIMED